Rosen Law Firm Reminds Pacira Investors of Class Action Lawsuit Deadline.Â
Rosen Law Firm, an international law firm specialising in investor rights, is reminding individuals who acquired securities of Pacira BioSciences, Inc. between August 2, 2023, and August 8, 2024 (referred to as the "Class Period") of an important deadline for those wishing to participate as lead plaintiffs in an ongoing class action. The deadline to file a motion to serve as a lead plaintiff is March 14, 2025.
Eligibility for Compensation Without Out-of-Pocket Expenses
If you acquired Pacira securities during the Class Period, you may be eligible for compensation without incurring any out-of-pocket expenses, as Rosen Law Firm offers a contingency fee structure. This means investors can participate in the class action without having to pay upfront legal fees.
How to Participate in the Pacira Class Action
To join the Pacira class action, visit this link, or contact Phillip Kim, Esq. toll-free at 866-767-3653. You can also reach out via email at case@rosenlegal.com for further details about the class action. A class action lawsuit has already been initiated.
Lead Plaintiff Role and Important Court Deadline
Investors interested in serving as the lead plaintiff for the case must file a motion with the Court by March 14, 2025. The lead plaintiff represents all other class members in managing the litigation process.
Allegations in the Class Action Lawsuit
The lawsuit alleges that Pacira BioSciences made false and misleading statements during the Class Period regarding its patent protections for Exparel, a key product for the company. These statements gave investors a false perception that Pacira had robust protections for Exparel's patents, which were vital for the company’s future marketing, production, and sales.
However, Pacira was aware that the ‘495 patent did not offer the level of protection that had been publicly claimed. This became evident after a June 6, 2023 ruling by the New Jersey District Court, which favoured eVenus in a case that Pacira initiated in an unsuccessful attempt to protect Exparel. Despite knowing this, Pacira continued to make confident statements regarding the patent’s protection, which ultimately led to investor losses when the truth became known.
Deadline for Lead Plaintiff Motion
To participate in the Pacira class action, individuals must act before March 14, 2025, by either visiting the link provided or contacting Phillip Kim, Esq. for more information.
The Rosen Law Firm, P.A. is a leading international law firm specializing in securities class actions, shareholder derivative litigation, and investor rights. Founded by Laurence Rosen, the firm has established a stellar reputation for its successful track record in recovering significant settlements for investors globally. With a focus on providing top-tier legal representation, Rosen Law Firm has secured hundreds of millions of dollars for its clients in securities fraud cases and other complex legal matters.
Known for its commitment to transparency, aggressive litigation strategies, and client-centered approach, Rosen Law Firm has been consistently ranked among the top firms for securities class action settlements. The firm’s dedication to achieving justice for investors has earned it recognition from leading industry publications, including Law360 and Super Lawyers.
Rosen Law Firm Investigates Rigetti Computing for Potential Securities ClaimsÂ
